Serum levels of fibroblast growth factor‐21 are increased in chronic and acute renal dysfunction

Abstract

We demonstrate that circulating FGF-21 is increased in both CKD and AKD. Our results suggest renal excretion as a major route for FGF-21 elimination. The pathophysiological significance of these findings needs to be elucidated in more detail.